2m 2m 2m 2m 2m 2m 2m
PHATHOM PHARMA (PHAT)
NASDAQ
$8.86-$0.010 (-0.11%)
Price as of Aug 21, 2026 7:34 PM EDT- $717.6MMarket Cap
- -25.52%1-Year Change
- BiotechnologyIndustry
PHATHOM PHARMA (PHAT)
$8.86-$0.010 (-0.11%)
PHAT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.87 | ||
Change | +$0.27 (+3.14%) | ||
Open | $8.63 | ||
High | $8.90 | ||
Low | $8.59 | ||
Previous Close | $8.60 | ||
Volume | 979,410 | ||
30-Day Average Volume | 1,684,130 | ||
1-Week Change | -7.41% | ||
1-Month Change | -21.16% | ||
1-Year Change | -25.52% | ||
3-Year Change | -41.02% | ||
5-Year Change | -71.89% | ||
Fundamentals | |||
Shares Outstanding | 80.9M | ||
Total Assets | $327.1M | ||
Market Cap | $717.6M | ||
Enterprise Value | $699.7M | ||
Period: QTR TTM FY | |||
Revenue | $74.3M | ||
Net Income | -$17.6M | ||
Free Cash Flow | -$2.0M | ||
EBIT | -$12.3M | ||
EBITDA | -$12.2M | ||
Net Working Capital | $142.1M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -58 | ||
Enterprise Value/Revenue | 9 | ||
P/B | -2 | ||
P/E | -42 | ||
PEG | -1 | ||
Price/Free Cash Flow | -364 | ||
Price/Operating Cash Flow | -372 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue